Attached files
| file | filename |
|---|---|
| EX-31.1 - EX-31.1 - ARRAY BIOPHARMA INC | d74686exv31w1.htm |
| EX-32.0 - EX-32.0 - ARRAY BIOPHARMA INC | d74686exv32w0.htm |
| EX-31.2 - EX-31.2 - ARRAY BIOPHARMA INC | d74686exv31w2.htm |
| EX-10.51 - EX-10.51 - ARRAY BIOPHARMA INC | d74686exv10w51.htm |
| EX-10.37 - EX-10.37 - ARRAY BIOPHARMA INC | d74686exv10w37.htm |
| EX-10.38 - EX-10.38 - ARRAY BIOPHARMA INC | d74686exv10w38.htm |
| 10-K - FORM 10-K - ARRAY BIOPHARMA INC | d74686e10vk.htm |
EXHIBIT 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
The Board of Directors and Stockholders
Array BioPharma Inc.:
Array BioPharma Inc.:
We consent
to the incorporation by reference in the registration statements
(Form S-3 No. 333-161633 and Forms S-8 Nos. 333-163138, 333-158624, 333-155219, 333-139450,
333-132205, 333-100955 and 333-51348) of Array BioPharma Inc. of our
reports dated August 12,
2010, with respect to the balance sheets of Array BioPharma Inc. as of June 30, 2010 and 2009, and
the related statements of operations and comprehensive loss, stockholders’ equity (deficit) and
cash flows for each of the years in the three-year period ended June 30, 2010 and the effectiveness
of internal control over financial reporting as of June 30, 2010, which reports appear in the June
30, 2010 annual report on Form 10-K of Array BioPharma Inc.
/s/ KPMG LLP
Boulder, Colorado
August 12, 2010
August 12, 2010